MARKET

OSTX

OSTX

OS THERAPIES INCORPORATED
AMEX
1.250
0.000
0.00%
After Hours: 1.250 0 0.00% 19:30 10/23 EDT
OPEN
1.270
PREV CLOSE
1.250
HIGH
1.290
LOW
1.230
VOLUME
142.13K
TURNOVER
--
52 WEEK HIGH
2.250
52 WEEK LOW
1.150
MARKET CAP
58.51M
P/E (TTM)
-1.1715
1D
5D
1M
3M
1Y
5Y
1D
OS Therapies Announces Warrant Offer to Extend Runway
TipRanks · 6d ago
Weekly Report: what happened at OSTX last week (1012-1016)?
Weekly Report · 6d ago
Weekly Report: what happened at OSTX last week (1005-1009)?
Weekly Report · 10/12 09:45
Herlystic’s Strong Phase 2b Survival Data and Advancing Regulatory Milestones Support Unchanged $6 Price Target and Buy Rating on OSTX
TipRanks · 10/07 16:35
OS Therapies' OSAH Subsidiary Receives U.S. Department Of Agriculture Guidance On Commercial Deployment Pathway For OST-HER2 To Treat Canine Osteosarcoma
Benzinga · 10/07 12:40
OS Animal Health Receives USDA Feedback on Regulatory Pathway for OST-HER2 in Canine Osteosarcoma
Newsfile · 10/07 12:30
OS Therapies Reports Significant Three-Year Survival Data for Bone Cancer Treatment
Benzinga · 10/06 17:19
OS Therapies Incorporated (OSTX) Receives a Buy from Roth MKM
TipRanks · 10/06 16:35
More
About OSTX
OS Therapies Incorporated is a clinical-stage oncology company focused on the identification, development, and commercialization of new class immunotherapy candidates for solid tumors, beginning with osteosarcoma and other solid tumors. Its pipeline includes two drug technologies: OST-HER2 and OST-tADC. Its lead asset, OST-HER2, is an off-the-shelf immunotherapy, which is a type of cancer treatment that helps one’s immune system fight cancer, comprised of a genetically weakened and modified strain of Listeria monocytogenes, a species of bacteria that causes the infection listeriosis, that expresses HER2 peptides. OST-tADC is a tunable ADC with a plug-and-play platform that features tunable pH-sensitive silicone linkers (SiLinkers). Its clinical-stage cancer immunotherapy programs also include OST-AXAL for human papilloma virus (HPV)-associated cancers; OST-503 for non-small cell lung cancer (NSCLC) & glioblastoma; and OST-PSA for prostate cancer.

Webull offers OS Therapies Inc stock information, including AMEX: OSTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OSTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OSTX stock methods without spending real money on the virtual paper trading platform.